Our mission is to improve patient outcomes and expand healthcare access using AI tools to democratize echo, the most commonly used tool for detection of heart risk.

Heart disease is the #1 killer worldwide

Echocardiography (ultrasound of the heart) is the first test of choice for cardiologists since, compared to other imaging methods, as it’s

Less Expensive

More Mobile

Non-Invasive & Radiation Free

Us2.ai is building a future where everyone, from the most advanced tech-driven regions to the most resource-constrained communities, can have equal access to high quality, consistent, and inexpensive echo analysis, for a better heart and a better life.

Us2.ai is a spinoff with support from Singapore’s Agency for Science, Technology and Research (A*STAR), built upon a major cardiovascular research platform across 11 countries.  We’ve partnered with top-tier echo core labs in the US and Europe to revolutionize ultrasound bringing AI enhanced imaging to all of us. 



The company’s founders bring decades of experience building technology companies from zero to IPO, running echo core labs and leading global, cardiological clinical trials.  Together, we’ve partnered with data scientists from Singapore’s Bioinformatics Institute and the Institute for High-Performance Computing to make life easier for echo specialists everywhere.

News and Publications

Us2.ai granted new patent

We’re pleased to announce our new patent and commercial deals with AZ and Janssen

Us2.ai granted new patent | September 29, 2020

Astrazeneca partners with Us2.ai

Astrazeneca and Us2.ai attempting to meet huge need for better heart failure diagnosis.

Astrazeneca partners with Us2.ai | September 17, 2020

SG Innovate Talk

AI and the future of ultrasound imaging – an online webinar presented by SG Innovate.

SG Innovate Talk | August 18, 2020

Asia’s Changemakers

An exciting Asian Scientist interview on reading hearts with AI!

Asia’s Changemakers | August 14, 2020

Galen Growth HealthTech

Meet the CEO interview, part of our fantastic collaboration with Galen Growth HealthTech.

Galen Growth HealthTech | July 18, 2020

Building an AI business

Fun interview with The Edge on the foundation story and growth of our company.

Building an AI business | July 06, 2020

AstraZeneca and Us2.ai sign MOU

AstraZeneca and Us2.ai sign MOU at the Singapore Ministry of Trade

AstraZeneca and Us2.ai sign MOU | February 16, 2020

CNA988 Tech Talk

Going from 30 mins and hundreds of mouse clicks to read an echo to 2 minutes and 1 click.

CNA988 Tech Talk | February 15, 2020

Sequoia and EDBI lead round

Sequoia India and EDBI lead Seed round in preparation for commercial launch.

Sequoia and EDBI lead round | February 15, 2020

BioSpectrum Asia Feature

Medtech startup excited to clinch top prize (pages 29-31).

BioSpectrum Asia Feature | February 15, 2020

AHA 2019 Interview

Fun interview at the American Heart Association conference. 

AHA 2019 Interview | February 15, 2020

Money FM 89.3 Interview

Nice radio interview and opportunity to discuss the eko.ai story.

Money FM 89.3 Interview | February 15, 2020

eko.ai in Publications

Founding Team

Dr Carolyn Lam

Director of the Clinical & Translational Research Office, National Heart Centre of Singapore. Professor of Cardiology at Duke-NUS Graduate Medical School. Leads multiple global clinical trials.

Received the L’Oreal Women in Science award. Currently on the Editorial Boards of Circulation, and the European Journal of Heart Failure, with prior editorial posts at 10 other journals. Has published over 175 peer reviewed articles and books. Host of the weekly medical podcast Circulation on the Run, and co-host of the television show Body & Soul.

PhD Univ. Groningen. Masters Mayo Clinic. Stanford GSB exec. program.


James Hare

Co-founder and President of eDreams (2014 IPO), one of Europe’s largest e-commerce sites with a global presence in 44 countries and over €4.5 billion in annual bookings. Biz dev and marketing roles throughout US, Europe and Asia, with EFI, UbiSoft, Netscape and the World Economic Forum.

MBA Stanford. BA Harvard.

Dr Yoran Hummel

Founder and GM of the Groningen Imaging Core Lab, coordinating all echocardiographic logistics in several large multicenter global clinical trials. Cardiovascular researcher with a special interest in echocardiography, diastology and cardio-mechanics. 

More than 50 publications in peer reviewed journals on cardiotoxicity, genetics and point-of-care echo, but always with cardiac function/failure as common denominator. 

Phd Univ. Groningen.



Dr Martin Cowie

Chair of the European Society of Cardiology Digital Health Committe.  Chair of Cardiology, Imperial College London. Hon. Consultant Cardiologist, Royal Brompton Hospital. Ex-Chair British Society for Heart Failure. Member, European Society of Cardiology’s EU Affairs Committee. Major research interests in health technology assessment with a particular focus on new technologies: diagnostics, drugs or devices.

MSc in Epidemiology, London School of Hygiene and Tropical Medicine.

Dr Bijan Dorri

Advisor for Medical Technologies, A*STAR. Former CTO, GE Healthcare Systems, Molecular Imaging and CT. Affiliate Professor Univ. of Washington. Managing Director, China Technology Center, for GE.

PhD Univ. of Washington in Mechanical Engineering. BS in Chemical Engineering, Shiraz Univ.

Dr Ken Stein

Dr. Ken Stein is currently Senior Vice President and Chief Medical Officer for Rhythm Management and Global Health Policy at Boston Scientific.

Ken is a Phi Beta Kappa graduate of Harvard College, and earned his MD from New York University School of Medicine. He completed his medical internship, residency, cardiology and cardiac electrophysiology training at The New York-Presbyterian Hospital/Weill Cornell Medical Center. 

Jeremy Lim

Mr Jeremy Lim is Partner, Health & Life Sciences Asia Pacific, at Oliver Wyman. He advises senior officials at public sector agencies and has extensive experience consulting and advising multinational private and NGO clients on national and regional strategies for go-to-market plans and implementation, government engagement and public-private partnerships.

Jeremy is also active in academia, holding appointments at several universities. He teaches at the National University of Singapore (Saw Swee Hock School of Public Health, and Duke-NUS medical school), and in 2013 authored Myth or Magic: The Singapore Healthcare System, a book that draws lessons from the Singapore health system for health reform efforts in other countries.

Prior to joining Oliver Wyman, Jeremy trained in surgery and public health. He has worked in senior executive roles in both public and private sectors, including time spent as a senior official in the Ministry of Health Singapore where he was also involved in a number of ‘Whole of Government’ initiatives.

Dr Scott Solomon

Professor of Medicine, Harvard. Director, Noninvasive Cardiology, Brigham and Women’s Hospital. Director, Cardiac Imaging Core Lab, Brigham and Women’s Hospital. Doctor of Medicine, Harvard. AB Neuroscience, Williams College.

Dr Justin Ezekowitz

Professor, Division of Cardiology, University of Alberta. Director of the Heart Function Clinic, Mazankowski Alberta Heart Institute. Co-Director of the Canadian VIGOUR Centre.